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DOI 10.1186/s12889-016-3823-1RESEARCH ARTICLE Open AccessDeterminants of seasonal influenza
vaccination in pregnant women in
Valencia, Spain
R. Vila-Candel1,2* , P. Navarro-Illana2, E. Navarro-Illana2, E. Castro-Sánchez3, Kiri Duke2, F. J. Soriano-Vidal2,4,
J. Tuells5 and J. Díez-Domingo2,6Abstract
Background: In most countries the coverage of seasonal influenza vaccination in pregnant women is low. We
investigated the acceptance, reasons for rejection and professional involvement related to vaccine information in
pregnant women in Valencia, Spain.
Methods: Observational retrospective study in 200 pregnant women, 100 vaccinated and 100 unvaccinated, were
interviewed during the 2014/2015 vaccination campaign. Electronic medical records, immunization registry and
telephone interviews were used to determine reasons for vaccination and immunization rejection.
Results: 40.5% of pregnant women in the health department were vaccinated. The midwife was identified as
source of information for 89% of women. The vaccine was rejected due to low perceptions of risk of influenza
infection (23%), lack of information (19%), considering the vaccine as superfluous (16%), close proximity of delivery
date (13%) and fear of side effects (12%).
Conclusion: Pregnant women in Spain declined to be vaccinated due to under-estimation of the risk of
contracting or being harmed by influenza, and lack of information. Interventions aiming to optimize vaccination
coverage should include information addressing the safety and effectiveness of the current vaccine together with
improved professional training and motivation.
Keywords: Influenza Vaccines, Pregnancy, Acceptance, Influenza vaccine coverageBackground
Pregnancy is an independent risk factor for developing
severe seasonal influenza [1]. Many international organi-
zations recommend the administration of influenza vac-
cine to pregnant women [2, 3] since influenza infection
is associated with higher maternal morbidity and mortal-
ity, increased hospital admissions and worse perinatal
outcomes [4, 5].
Since 2004 influenza vaccination is recommended at
any stage of pregnancy due to the well documented
safety profile of the vaccine [6]. Despite its benefits, vac-
cination coverage among pregnant women remains low* Correspondence: rvila@hospital-ribera-.com
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(http://creativecommons.org/publicdomain/ze[7], according to international studies. In Spain there are
no published data on influenza vaccination coverage in
pregnant women, despite the clear benefits derived from
close epidemiological surveillance of such coverage [8].
Different authors [1, 9] have highlighted that vaccin-
ation recommendation by health professionals is the
main reason why women choose to be vaccinated
against influenza. However, lack of information by health
professionals also remains a frequently cited determining
factor for rejecting vaccination [10]. Other studies have
identified additional influences such as emotional or psy-
chological factors (subjective emotional experiences, e.g.
fear of side effects, doubts about the effectiveness of the
vaccine, fear of needles/pain etc.) or under-estimation of
personal risk (beliefs about the limited severity of the ill-
ness, influenza vaccination being unimportant, or non-le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Telephone questionnaire for vaccinated and
unvaccinated women
Vaccinated women (n = 100)
1. Where did you receive information about the influenza vaccine while
pregnant?
2. Which healthcare provider recommended the vaccine to you? If it
was not a healthcare provider, who was it?
3. Would you choose to be vaccinated again in a future pregnancy
under the same circumstances?
Unvaccinated women (n = 100)
1. Have you heard about the vaccine? If so, which healthcare provider
recommended it to you?
2. Did you know whether you were eligible to be vaccinated?
3. Which was you reason for vaccine rejection?
4. Would you choose to be vaccinated again in a future pregnancy
under the same circumstances?
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ing to low vaccination rates.
Since a variety of studies have explored the scope of
professional advice and its impact on vaccination accept-
ance, such evidence could be used to inform optimal
strategies to improve vaccination coverage in this popu-
lation at-risk [3, 14–16]. In Spain, pregnant women are
entitled to receive free influenza vaccination.
The aim of the study was to investigate the acceptance
of influenza vaccination amongst pregnant women in
Valencia (Spain) and the reasons expressed for vaccin-
ation rejection. We also analyzed the knowledge that
pregnant women had about the vaccine and described
which healthcare professional was more frequently in-
volved in the vaccination decision-making process dur-
ing pregnancy.
Methods
We conducted an observational, descriptive, retrospect-
ive study in women seen at La Ribera healthcare depart-
ment in Valencia (Spain) for pregnancy follow-up and
delivery between October 1, 2014 and January 31, 2015.
This healthcare department has a La Ribera University
Hospital (HULR), which is a tertiary healthcare center
with 300 beds. The hospital and the healthcare depart-
ment provide health services to 250,000 people
approximately.
In the community (or primary care) we have family
doctors, community nurses, community midwives and
gynecologists as baseline care providers. One provider
complements the other provider’s services and pregnant
patients are followed up by the family doctor, the com-
munity midwife and the gynecologist.
During the study period there were 644 deliveries, of
those 100 were not resident of the catchment area and
124 there was no information about the vaccination sta-
tus in the vaccine registry Sistema de Información
Vacunal (SIV) [17].
Of the remaining 420 women, 170 (40.5%) had re-
ceived influenza vaccination. After reviewing the elec-
tronic charts we excluded women under 18 years,
allergic to any of the vaccine components or women
with communication barriers.
Of the remaining, we selected 100 women to be inter-
viewed for each group (vaccinated and unvaccinated)
through simple randomization sampling. Women were
contacted by telephone in Feb-March 2015, and were
interviewed after accepting a verbal informed consent.
We conducted a three-question telephone survey and
asked vaccinated women about the source of the infor-
mation of influenza vaccine, the health provider involved
in recommending the vaccination, and whether they
would opt to be vaccinated again in their next pregnancy
(Table 1).We also conducted a four-question telephone survey
on unvaccinated women, where we asked whether they
had heard about the vaccine and, if so, which healthcare
provider recommended it, the reasons for vaccine rejec-
tion, their knowledge about the vaccine and whether
they would have the vaccine given in their next preg-
nancy (Table 1).
Other variables collected from the interview and the
review of the electronic clinical notes included age,
country of origin, gestational age at delivery, parity, and
chronic underlying disease (asthma, diabetes, heart dis-
ease and immunosuppression).
The sample size was calculated to assess differences in
the percentage of pregnant women that received advice
from the health provider for influenza vaccination. We
estimated that 50% of vaccinated women received advice
and 40% of the unvaccinated. With an error of 5% and a
power of 85%, the sample size needed was 194 women
in total, 97 per group.
Bivariate analysis was performed using Chi-square; for
risk factors for vaccination, an odds ratio (OR) with a
95% CI, was calculated. The significance level was set at
p < 0.05.
Ethics
The study was conducted according to the Declaration
of Helsinki and current legislation, and received approval
by the HULR Research Ethics Committee and the Spanish
Medicines and Medical Devices Agency.
Results
We contacted 141 vaccinated pregnant women, of those
41 (29%) did not participate: 35 (85.3%) did not answer
the telephone, 4 (9.8%) declined to participate in the
study and 2 (4.9%) were excluded due to communication
difficulties. All of the vaccinated pregnant women
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the information on SIV.
On the other hand, 161 unvaccinated women were
also contacted and 61 (37.9%) did not participate: 56
(91.8%) did not answer the telephone, 4 (6.6%) did not
accepted participation and 1 (1.6%) was excluded due to
communication barriers. All of the women with no in-
formation about the vaccination status in SIV confirmed
having not received the vaccine.
The mean age was 31.5 ± 5.2 years (median 32.50,
range 18–42), mean gestational age at delivery was
39.14 ± 1.5 weeks (range 34–42), and 47.2% (94/200)Table 2 Characteristics of pregnant women in study (N = 200)
Vaccin
(n = 10
n
Country of Origin Foreign 20
Spanish 80
Age (years) <25 18
25–35 63
>35 19
Parity 1 51
2-mar 38
>3 11
Gestational <37 9
Age (weeks) 37–42 88
>42 3
Asthmab No 97
Yes 34.0
Diabetes Mellitusb No 100
Yes 0
Cardiac Pathologyb No 100
Yes 0
Immunosuppressionb No 100
Yes 0
Low Risk Pregnancyc No 34
Yes 66
Pregnancy-induced Hypertensionc No 96
Yes 4
Thyroid Diseasec No 92
Yes 8
Smoker statusc No 84
Yes 16
Vaccinated previous season (2013–14) No 91
Yes 9
a P-value: based on chi-square test; N/A: insufficient cell number to perform chi-squ
b Pre-gestational disease
c Gestational disease or status during pregnancywomen were primiparous. The mean gestational age of
vaccinated women was 32.28 ± 3.7 weeks (range 25–39).
The characteristics of both groups, vaccinated and un-
vaccinated are shown in Table 2, showing no statistical
differences between them. Only 23% (3/13) of women
with comorbidities (5.5 % asthma [11/200]; 0.5% diabetes
[1/200]; 0.5% cardiac pathology [1/200]) were vaccinated,
and 36% (36/100) women with at-risk pregnancy re-
ceived vaccination. We observed that 40% (6/15) of the
group who received the vaccine during the previous sea-
son (2013–14) rejected the vaccination during the
pregnancy.ated Unvaccinated
0) (n = 100)
% n % P-valuea
20.0 21 21.0
80.0 79 79.0 0.831
18.0 9 9.0
63.0 66 66.0
19.0 25 25.0 0.143
51.0 43 43.0
38.0 50 50.0
11.0 7 7.0 0.201
9.0 10 10.0
88.0 88 88.0
3.0 2 2.0 0.881
97.0 92 92.0
3.0 8 8.0 0.121
100.0 99 99.0
0.0 1 1.0 0.316
100.0 99 99.0
0.0 1 1.0 0.316
100.0 100 100.0
0.0 0 0.0 N/A
34.0 40 40.0
66.0 60 60.0 0.380
96.0 97 97.0
4.0 3 3.0 0.700
92.0 89 89.0
8.0 11 11.0 0.469
84.0 79 79.0
16.0 21 21.0 0.363
91.0 94 94.0
9.0 6 6.0 0.421
are analysis
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When vaccinated women were asked about the source
of information regarding the vaccine, 98% (98/100)
recalled being informed in their primary health care cen-
ter. 1 % knew about it in advance as they were health
professionals and another 1% received information via
mass media such as radio, television or public health
communication campaigns.
The information and recommendation of vaccination
came mainly from their midwives (89%), in 9% (9/100)
from the family doctor and 2% of women did not pro-
vide any information.
Of the vaccinated, 99% would have the influenza vac-
cine again in a future pregnancy should they find them-
selves in comparable health conditions.
Influenza vaccine rejection
14% of women had not heard of influenza vaccination
during pregnancy. Those who did have information had
mainly received it from their midwife (n = 40) or other
sources such as their family doctor (n = 6) or
gynecologist (n = 1). Other information channels in-
cluded public health advertising campaigns (n = 12), rela-
tives or friends (n = 14) or at work (n = 2). Of the total
sample, 6% (12/200) were health care professionals and
knew about the vaccine, however, 91.6% (11/12) of these
women declined to be vaccinated [OR = 13.1, 95% CI:
1.6–102.6; p = 0.02].Fig. 1 Reasons for influenza vaccine rejection during pregnancyWhen asked if they were eligible to be vaccinated, 59%
(59/100) responded positively, 4% (4/100) recognized
they could not receive it at the time and 12% (12/100)
did not know.
The reasons provided by women to decline the influ-
enza vaccine during pregnancy are presented in Fig. 1.
Women also stated that the main reason for rejecting
vaccination was under-estimation of the risk, reflected in
perceptions of no risk of contracting the illness whilst
being pregnant (23%), followed by a lack of information
(19%), considering the vaccine as non-essential (16%)
and avoiding it due to the close delivery date (13).
When women were asked if they would opt to be vac-
cinated in a future pregnancy should they remain in
similar health condition, 18% (18/100) accepted, 65%
(65/100) would again reject it and 17% (17/100) did not
know what to answer.
Discussion
This study suggests that pregnant women do not vaccin-
ate against influenza due to the low perception of risk
and a lack of evidenced-based information provided by
health professionals.
No significant differences were identified in the
socio-demographic and obstetric characteristics be-
tween vaccinated and unvaccinated pregnant women.
Seasonal influenza remains a global public health
problem [18] and demands specific strategies and a
Vila-Candel et al. BMC Public Health  (2016) 16:1173 Page 5 of 7particular focus on pregnant women as a high-risk
group for seasonal flu [19, 20].
Influenza vaccine acceptance
Regarding vaccination status before pregnancy, we ob-
served that having previously received the flu vaccin-
ation was positively associated to acceptance during
pregnancy [21]. However, a medical history involving a
risk prior to pregnancy, such as having asthma, diabetes
or a heart disease during pregnancy, was not associated
with a higher influenza vaccination rate.
In relation to the knowledge of women who reported
having received information about the vaccine, both vac-
cinated and unvaccinated women agreed that the mid-
wife had been the main source of information, in
agreement with a similar study conducted in the UK
[22]. Although in other countries the family doctor has
been reported as the main information agent [2, 16, 23],
possibly owing to different healthcare models.
Concerning the intention to being re-vaccinated in a
future pregnancy were the women to be in the same
conditions, the surveyed women presented mixed re-
sponses. Virtually all vaccinated women agreed they
would be vaccinated as well, while, in contrast, those un-
vaccinated would decline, coinciding with certain studies
[24, 25]. As for unvaccinated pregnant women, we ob-
served that those who were healthcare professionals
were paradoxically much more likely to decline to be
vaccinated, as seen in other studies [2, 26].
In all, reasons for vaccination rejection can be classi-
fied according to four themes:
1) Lack of knowledge and information
The lack of knowledge due to insufficient
information (19%), together with a lack of
vaccination support from healthcare professionals
(4%), accounted for 23% of vaccination refusal
reasons, corroborating previous results [2, 10, 27, 28].
These findings highlight the need to improve
influenza vaccination promotion activities conducted
by healthcare professionals for pregnant patients [3].
We believe that information should be timely
provided, within a meaningful discussion and a shared
decision-making perspective [9, 11] that favors vaccine
acceptance or rejection within an optimum time
frame [25]. Ideally, this discussion should reflect the
information on the causes, symptoms, side effects and
the importance of the disease to support their
decisions.
However, the provision of accurate and quality
information would be insufficient to ensure adequate
health outcomes if the influence of health literacy of
patients is not accounted for. Health literacy links
knowledge and user skills in appropriate decisionmaking related to health and social care [29]. A low
health literacy level has been linked to poor health
outcomes, including low vaccination rates [30]. In
our study, unvaccinated women had accessed a
greater number of information channels, compared
with vaccinated women. This difference possibly
reflects a need to confirm personal perceptions
about the vaccine that would not fit or be accepted
by the mainstream vaccination narrative [31], or that
are not in agreement with the information received
from each channel [25].
Therefore, in order to increase the number of
vaccinated pregnant women, public health strategies
could take advantage of intervention synergies,
combining efficient communication materials with
information regarding immunization and vaccine
safety, along with continuous education strategies for
healthcare professionals. Since midwives already
achieve the highest rate of influenza vaccination
recommendation, and as main source of information
according to women [9, 24], their leadership on the
design, implementation and evaluation of these
multiple interventions would seem logical [29].
2) Pregnant women feel the vaccine is unnecessary,
ineffective and that they have a low perception of
risk of influenza infection
16% of women surveyed considered the vaccine
unnecessary. Such idea may be supported by
considering that the risk of contracting the disease
whilst pregnant is non existent (23%). Pregnant
women could also assume that an absence of
influenza infection in the pre-pregnancy period
could be related to their lifestyle, and since they had
not changed it, the infection would also not occur
during pregnancy either. Additionally, 3% of the
women considered the vaccine to be ineffective,
failing to realize the wider effect that an insufficient
number of vaccinated women would have on the
effectiveness of the vaccine at population level [32].
Furthermore, 13% of surveyed women believed that
vaccination was unnecessary due to the imminent
childbirth date. Such position obviously ignores the
benefits that acquired immunity would provide for
the newborn after delivery [27], and that may result
in a significant reduction in perinatal infections [6].
3) Health risk perceptions
The side effects of the vaccine were a concern for
12% of women. This apprehension referred not only
to their own health but also the babies’, and would
explain the lack of vaccine acceptance during
pregnancy. Such negative perceptions, however, do
not seem to be endorsed by the existing on the link
between vaccination and adverse perinatal and
maternal outcomes [8, 32–34].
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obtained by other groups [1, 27, 35], where more
than half of vaccination rejections stemmed from a
perceived lack of data on the efficacy and safety of
vaccine. Due to the determinant influence of these
perceptions and beliefs, it is essential to carry out
qualitative studies that would inform and facilitate
improvement interventions.
4) Medical contraindications
In 2% (2/100) of the cases the vaccine could not be
administered due to transient and self-limited infectious
processes, simply requiring a postponement of the
inoculation [31, 32].
Conclusions
Pregnant women in Spain declined to be vaccinated due
to an under-estimation of the risk of contracting or be-
ing harmed by influenza and lack of information. In
order to increase the acceptance of influenza vaccine it
would be necessary to improve the information offered
to women by all members of the multidisciplinary team
and to integrate the therapeutic advice onto the care
path for pregnant women.
Abbreviations
HULR: Hospital Universitario de la Ribera; SIV: Sistema de Información vacunal
(vaccination registry)
Acknowledgements
We are grateful to all the staff at the hospital and health facilities of La
Ribera University Hospital, and their support with this research.
Funding
This project has been funded by a grant awarded by Hospital Universitario
de la Ribera PBR24/15. Enrique Castro-Sánchez is affiliated to the National
Institute for Health Research Health Protection Research Unit (NIHR HPRU) in
Healthcare Associated Infection and Antimicrobial Resistance at Imperial
College London, in partnership with Public Health England. The views
expressed are those of the authors and not necessarily those of the NHS, the
NIHR, the Department of Health, or Public Health England. ECS has received an
Early Career Research Fellowship from the Antimicrobial Research Collaborative
at Imperial College London, and acknowledges the support of the Florence
Nightingale Foundation.
Availability of data and material
The original dataset is available from the corresponding author on
reasonable request.
Authors’ contributions
RVC drafted the manuscript. JDD, PNI, FJSV and JT were involved in
conceptualizing the study. RVC, PNI and ECS conducted the data analyses.
All authors were involved in writing the manuscript and approve of its final
version.
Competing of interests
The authors declare that they have no competing of interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Participants provided informed consent to participate in the study, and the
Human Ethics Committee at Hospital Universitario de La Ribera ResearchEthics Committee and Research Commission and the Spanish Medicines and
Medical Devices Agency approved the study (HULR15/12–01).
Author details
1Midwifery at La Ribera Hospital Health Department, Carretera Corbera, km 1,
46600 Alzira, Valencia, Spain. 2Faculty of Nursing, Universidad Católica de
Valencia” San Vicente Mártir”, c/ Espartero, 7. 46007 Valencia, Spain. 3National
Institute for Health Research Health Protection Research Unit (NIHR HPRU) In
Healthcare Associated Infection and Antimicrobial Resistance at Imperial
College London, Du Cane Road, London W12 0NN, UK. 4Xàtiva-Ontinyent
Health Department, Ausias March, 46.800 Xativa, Spain. 5Cátedra de
Vacunología Balmis, University of Alicante, Carretera de San Vicente del
Raspeig, s/n. 03690, San Vicente del Raspeig, Alicante, Spain. 6Vaccine
Research, Fundación para el Fomento de la Investigación Sanitaria y
Biomédica de la Comunitat Valenciana, FISABIO-Public Health, Avda.
Catalunya, 21. 46020 Valencia, Spain.
Received: 18 August 2016 Accepted: 4 November 2016
References
1. Yuen CYS, Tarrant M. A Comprehensive Review of Influenza and Influenza
Vaccination During Pregnancy. J Perinat Neonatal Nurs. 2014;28:261–70.
2. Panda B, Stiller R, Panda A. Influenza vaccination during pregnancy and
factors for lacking compliance with current CDC guidelines. J Matern Fetal
Neonatal Med. 2011;24:402–6. doi:10.3109/14767058.2010.497882.
3. Yuen CYS, Tarrant M. Determinants of uptake of influenza vaccination
among pregnant women - A systematic review. Vaccine. 2014;32:4602–13.
doi:10.1016/j.vaccine.2014.06.067.
4. McNeil SA, Dodds LA, Fell DB, Allen VM, Halperin BA, Steinhoff MC, et al.
Effect of respiratory hospitalization during pregnancy on infant outcomes.
Am J Obstet Gynecol 2011;204. doi:10.1016/j.ajog.2011.04.031.
5. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF, Snowden MS, Wood LB, et al.
Maternal morbidity and perinatal outcomes among pregnant women with
respiratory hospitalizations during influenza season. Am J Obstet Gynecol.
2003;189:1705–12. doi:10.1016/S0002-9378(03)00857-3.
6. Munoz FM. Safety of influenza vaccines in pregnant women. Am J Obstet
Gynecol 2012;207. doi:10.1016/j.ajog.2012.06.072.
7. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of
recommended adult populations, U.S., 1989–2005. Vaccine. 2008;26:1786–93.
doi:10.1016/j.vaccine.2008.01.040.
8. Vilca Yengle LM, Campins Martí M, Cabero Roura L, Rodrigo Pendás JÁ,
Martínez Gómez X, Hermosilla Pérez E, et al. Influenza vaccination in
pregnant women. Coverage, practices and knowledge among obstetricians.
Med Clin (Barc). 2010;134:146–51.
9. Regan AK, Mak DB, Hauck YL, Gibbs R, Tracey L, Effler P V. Trends in
seasonal influenza vaccine uptake during pregnancy in Western
Australia: Implications for midwives. Women Birth 2016. doi:10.1016/j.
wombi.2016.01.009.
10. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine
hesitancy: An overview. Hum Vaccin Immunother. 2013;9(8):1763–73.
doi:10.4161/hv.24657.
11. Lester RT, McGeer A, Tomlinson G, Detsky AS. Use of, effectiveness of, and
attitudes regarding influenza vaccine among house staff. Infect Control
Hosp Epidemiol. 2003;24:839–44. doi:10.1086/502146.
12. Ofstead CL, Tucker SJ, Beebe TJ, Poland GA. Influenza vaccination among
registered nurses: information receipt, knowledge, and decision-making at
an institution with a multifaceted educational program. Infect Control Hosp
Epidemiol. 2008;29:99–106. doi:10.1086/526431.
13. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to
vaccination: A critical review. Soc Sci Med. 2014;112:1–11. doi:10.1016/j.
socscimed.2014.04.018.
14. Perlin JB, Septimus EJ, Cormier SB, Moody JA, Hickok JD, Bracken RM.
Developing a program to increase seasonal influenza vaccination of
healthcare workers: lessons from a system of community hospitals.
J Healthc Qual. 2013;35:5–15. doi:10.1111/jhq.12005.
15. Henninger M, Naleway A, Crane B, Donahue J, Irving S. Predictors of seasonal
influenza vaccination during pregnancy. Obstet Gynecol. 2013;121:741–9.
doi:10.1097/AOG.0b013e3182878a5a.
16. Privileggio L, Falchi A, Grisoni M-L, Souty C, Turbelin C, Fonteneau L, et al.
Rates of immunization against pandemic and seasonal influenza in persons
Vila-Candel et al. BMC Public Health  (2016) 16:1173 Page 7 of 7at high risk of severe influenza illness: a cross-sectional study among
patients of the French Sentinelles general practitioners. BMC Public Health.
2013;13:246. doi:10.1186/1471-2458-13-246.
17. Pérez-Vilar S, Díez-Domingo J, López-Lacort M, Martínez-Úbeda S, Martinez-
Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded,
against rotavirus hospitalizations in the Valencia Region, Spain. BMC Infect
Dis. 2015;15:92. doi:10.1186/s12879-015-0811-5.
18. Puig-Barberá J, Tormos A, Trushakova S, Sominina A, Pisareva M, Ciblak MA,
et al. The Global Influenza Hospital Surveillance Network (GIHSN): A new
platform to describe the epidemiology of severe influenza. Influenza Other
Respi Viruses. 2015;9:277–86. doi:10.1111/irv.12335.
19. Stockwell MS, Westhoff C, Kharbanda EO, Vargas CY, Camargo S, Vawdrey
DK, et al. Influenza vaccine text message reminders for urban, low-income
pregnant women: A randomized controlled trial. Am J Public Health
2014;104. doi:10.2105/AJPH.2013.301620.
20. France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, et al.
Impact of maternal influenza vaccination during pregnancy on the
incidence of acute respiratory illness visits among infants. Arch Pediatr
Adolesc Med. 2006;160:1277–83.
21. Gorman JR, Brewer NT, Wang JB, Chambers CD. Theory-based predictors of
influenza vaccination among pregnant women. Vaccine. 2012;31:213–8.
doi:10.1016/j.vaccine.2012.10.064.
22. Ishola DA, Permalloo N, Cordery RJ, Anderson SR. Midwives’ influenza
vaccine uptake and their views on vaccination of pregnant women. J Public
Health (United Kingdom). 2013;35:570–7. doi:10.1093/pubmed/fds109.
23. Laenen J, Roelants M, Devlieger R, Vandermeulen C. Influenza and pertussis
vaccination coverage in pregnant women. Vaccine. 2015;33:2125–31. doi:10.
1016/j.vaccine.2015.03.020.
24. Meharry PM, Colson ER, Grizas AP, Stiller R, Vázquez M. Reasons why
women accept or reject the trivalent inactivated influenza vaccine (TIV)
during pregnancy. Matern Child Health J. 2013;17:156–64. doi:10.1007/
s10995-012-0957-3.
25. Maher L, Dawson A, Wiley K, Hope K, Torvaldsen S, Lawrence G, et al.
Influenza vaccination during pregnancy: a qualitative study of the
knowledge, attitudes, beliefs, and practices of general practitioners in
Central and South-Western Sydney. BMC Fam Pract. 2014;15:102.
doi:10.1186/1471-2296-15-102.
26. Torner N, Godoy P, Soldevila N, Toledo D, Rius C, Domínguez A. Primary
health care professionals attitudes towards influenza immunzation in
Catalonia. Aten Primaria. 2015;48:192–9. doi:10.1016/j.aprim.2014.09.014.
27. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in
pregnancy: current evidence and selected national policies. Lancet Infect
Dis. 2008;8:44–52.
28. Falomir-Pichastor JM, Toscani L, Despointes SH. Determinants of flu
vaccination among nurses: The effects of group identification and
professional responsibility. Appl Psychol. 2009;58:42–58. doi:10.1111/j.1464-
0597.2008.00381.x.
29. Castro-Sánchez E, Chang PWS, Vila-Candel R, Escobedo AA, Holmes AH.
Health literacy and infectious diseases: why does it matter? Int J Infect Dis.
2016;43:103–10. doi:10.1016/j.ijid.2015.12.019.
30. Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Crotty K. Low health
literacy and health outcomes: An updated systematic review. Ann Intern
Med. 2011;155:97–107. doi:10.7326/0003-4819-155-2-201107190-00005.
31. Yudin MH, Salaripour M, Sgro MD. Pregnant women’s knowledge of
influenza and the use and safety of the influenza vaccine during pregnancy.
J Obstet Gynaecol Can. 2009;31:120–5. doi:10.1016/S1701-2163(16)34095-6.
32. Tamma PD, Ault KA, Del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of
influenza vaccination during pregnancy. Am J Obstet Gynecol.
2009;201:547–52.
33. Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD.
Inactivated influenza vaccine during pregnancy and risks for adverse
obstetric events. Obstet Gynecol. 2013;122:659–67. doi:10.1097/AOG.
0b013e3182a1118a.
34. Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, DeStefano
F. Maternal Influenza Vaccine and Risks for Preterm or Small for Gestational
Age Birth. J Pediatr. 2016;164:1051–7.e2. doi:10.1016/j.jpeds.2014.01.037.
35. Christian LM. Optimizing benefits of influenza virus vaccination during
pregnancy: Potential behavioral risk factors and interventions. Vaccine.
2014;32:2958–64.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
